Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics
Open Access
- 10 June 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 165 (3) , 329-337
Abstract
A large body of evidence indicates that the immune microenvironment controls tumour development. Primary central nervous system lymphomas (PCNSL) are aggressive tumours growing in the central nervous system (CNS). To evaluate the role and characteristics of this immune-privileged site in anti-tumour defences, we compared the cellular and molecular immune microenvironments of growing murine lymphoma B cells injected into the brain or the spleen. In the brain, immune cells, including dendritic cells and T lymphocytes with a large proportion of CD4+forkhead box P3 (FoxP3+) regulatory T cells, rapidly infiltrated the tumour microenvironment. These populations also increased in number in the spleen. The T cell cytokine profiles in tumour-bearing mice were similar in the two sites, with predominant T helper type 1 (Th1)/Th17 polarization after polyclonal stimulation, although some interleukin (IL)-4 could also be found. We demonstrated that these T cells have anti-tumour activity in the CNS, although less than in the spleen: nude mice that received lymphoma cells intracerebrally died significantly earlier than immunocompetent animals. These results demonstrate that the brain is able to recruit all the major actors to mount a specific anti-tumour immune response against lymphoma.Keywords
This publication has 34 references indexed in Scilit:
- Current Management of Primary Central Nervous System LymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- What is immune privilege (not)?Trends in Immunology, 2007
- Rat choroid plexuses contain myeloid progenitors capable of differentiation toward macrophage or dendritic cell phenotypesGlia, 2006
- Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.Clinical Cancer Research, 2006
- A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 casesBlood, 2005
- Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in VivoScience, 2005
- Impaired capacity for upregulation of MHC class II in tumor‐associated microgliaGlia, 2005
- Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomasJournal of Neuroimmunology, 2002
- Site-specific immune response to implanted gliomasJournal of Neurosurgery, 2001
- Brain Dendritic Cells and Macrophages/Microglia in Central Nervous System InflammationThe Journal of Immunology, 2001